Trial intelligence / Profile preview

Zinc Sulfate for Chemoradiotherapy-Induced Taste Alterations in Oral Cancer

NCT03824925Phase 3Completed

Sponsor
Dow University of Health Sciences
Start
Dec 2016
Primary completion
Oct 2018
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of zinc in dysgeusia, sponsored by Dow University of Health Sciences. Started Dec 2016; status: completed.

02

Drugs

zinc
03

Conditions

dysgeusia

Beyond the preview

Go deeper on NCT03824925.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03824925.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call